Fondaparinux Sodium (Xa Inhibition) [16103X]

Test Code

CPT Codes

Preferred Specimen
1 mL citrated plasma collected in a 3.2% sodium citrate (light blue-top) tube

Minimum Volume
0.5 mL

Transport Container
Sterile, plastic screw-cap vial

Transport Temperature

Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 21 days

Anti-Xa Chromogenic

Setup Schedule
Set up: Mon-Fri; Report available: Next day

Reference Range
Not established

Clinical Significance
Fondaparinux sodium (Arixtra) is a factor Xa inhibitor indicated for the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism in certain patient populations. The antithrombotic activity of Arixtra is the result of antithrombin III-mediated selective inhibition of Factor Xa. Neutralization of factor Xa interrupts thrombin formation and thrombus development. The anti-Factor Xa activity of the drug can be measured using the chromogenic anti-Xa method using Arixtra as the calibrator.

Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.